Clinical and demOgRaphic features of patients with uncontrolled Severe Asthma in Russia (CORSAR) - CORSAR

Study identifier:D5180R00037

ClinicalTrials.gov identifier:NCT06472310

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

An observational multicenter cross-sectional study of patients with uncontrolled severe asthma in the population of the Russian Federation

Medical condition

Severe Asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

5000

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 06 Jun 2024
Estimated Primary Completion Date: 30 Jun 2027
Estimated Study Completion Date: 30 Jun 2027

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria